06
Mar

Japanese pharma giant Astellas won FDA approval for an antifungal treatment targeting two rare but dangerous infections, the latest drugmaker to take advantage of new incentives for anti-infective products.

…read more

Source: Astellas bags FDA approval for a new anti-infective

    

0 No comments